💸 The Tape

Governor Abigail Spanberger vetoed Virginia's adult-use cannabis sales legislation on Tuesday, killing HB 642 and SB 542 and ensuring that the commonwealth remains the only state in America where adults can legally possess cannabis but have no regulated way to buy it. Five years after legalization. Three governor vetoes. Zero retail stores.

The veto, while not surprising after lawmakers rejected Spanberger's proposed amendments last month, is no less devastating for an industry, a legislature, and a state that has been running in circles since 2021.

The Governor's Justification

Spanberger framed the veto as a matter of implementation, not opposition. She said she shares the General Assembly's goal of establishing a safe, legal, and well-regulated cannabis retail marketplace, but argued that the bill as written lacked the timeline, structure, and resources to be successfully implemented.

She pointed to lessons from other states, saying she had consulted with governors who had already launched adult-use markets. In an April interview, Spanberger said her amendments were intended to clearly define what a legal market looks like and ensure Virginia had adequate time to build out regulatory infrastructure, enforcement capacity, and consumer protections before retail sales began.

On the surface, those sound like reasonable concerns. In practice, what Spanberger proposed went far beyond implementation logistics.

Her substitute bill would have delayed the sales launch from January 2027 to July 2027, reduced the number of retail stores from 350 to 200, increased the excise tax from 6% to 8% by 2029, and — most controversially — introduced a battery of new criminal penalties that lawmakers said contradicted the entire purpose of legalization. Public consumption would have shifted from a $25 civil fine to a Class 4 misdemeanor. Possessing cannabis under age 21 would have become a Class 1 misdemeanor with a mandatory $500 fine. And illegally transporting 50 pounds or more of marijuana would have carried a Class 2 felony — punishable by 20 years to life in prison.

Bill sponsor Sen. Lashrecse Aird (D-Henrico) didn't mince words, saying that any version of the legislation that treats cannabis offenses with the same severity as near-first-degree murder was "always going to be a nonstarter."

The Lawmakers' Response

The reaction from the bill's sponsors was swift and pointed. Aird and Del. Paul Krizek (D-Fairfax) issued a joint statement saying the veto ignores the reality that cannabis is already being sold every day across Virginia, and that the only question is whether leaders will ensure those sales occur within a legal, regulated market or continue turning a blind eye to a booming illicit market.

"Virginians deserve better than continued inaction veiled behind excuses about getting it right," they added.

Chelsea Higgs Wise, executive director of Marijuana Justice, called the veto a decision to extend chaos rather than move toward a transparent, accountable retail system. NORML's JM Pedini was harsher, calling it outrageous that five years after Virginia lawmakers first approved legalization, there still exists no regulated cannabis sales system outside of the state-licensed medical program.

The criticism carries particular sting because Spanberger said in an interview last August that she would sign the legislation, stating she supports a legal marketplace for cannabis. Sixty percent of registered Virginia voters favor allowing licensed retail sales, according to polling from the Wason Center at Christopher Newport University. Over 2,300 Virginians contacted the governor's office in support of the bills.

The Medical Market: Who's Already There

While retail sales remain blocked, Virginia does operate a limited medical cannabis program through five licensed pharmaceutical processors — all held by multi-state operators. As of early 2026, those licensees operate 23 dispensing facilities statewide.

Green Thumb Industries covers Northern Virginia. Jushi Holdings also operates in Northern Virginia, where it has a $30 million facility expansion underway near Manassas. Verano holds the Southwest Virginia territory. AYR Wellness serves Western Virginia. And operations formerly under The Cannabist Company — recently acquired by Curaleaf — cover South Central and Eastern Virginia through the gLeaf and Cannabist brands.

Each processor holds a vertically integrated license covering cultivation, manufacturing, and dispensing. Under the vetoed legislation, these operators could have converted to dual-use licenses for a $10 million fee, giving them immediate access to adult-use sales — a significant advantage over new entrants who would need months to build out facilities and begin production.

Virginia's unregulated cannabis market is estimated at roughly $3 billion. Industry projections suggest a regulated adult-use market could generate $780 million in its first year and exceed $1 billion by year two. The combined tax structure proposed in the bill — approximately 12.3% to 14.8% depending on locality — was projected to deliver up to $400 million in tax revenue over the first five years.

All of that remains on the shelf.

What Happens Next

The veto pushes the entire process back to the 2027 legislative session, which convenes in January. Lawmakers will need to draft new legislation, negotiate with a governor who has now demonstrated willingness to veto even legislation from her own party, and rebuild consensus around a framework that addresses Spanberger's stated concerns without reintroducing the criminal penalties that made her substitute unacceptable to the legislature.

Realistically, even an optimistic timeline means new legislation wouldn't pass until spring 2027 at the earliest, with a market launch unlikely before late 2027 or early 2028. That's another full year — at minimum — of unregulated sales, lost tax revenue, and continued uncertainty for the MSOs that have already invested tens of millions in Virginia infrastructure.

Spanberger said she is "committed to working with members of the General Assembly, stakeholders, and law enforcement to get this right." Whether that commitment translates into meaningful collaboration — rather than another round of last-minute rewrites and ultimatums — will determine whether Virginia's cannabis market ever actually launches during her tenure.

For now, Virginia holds the distinction no state wants: legal possession, illegal purchase, and a governor from the same party that legalized it who just killed the only path to fixing it.

The illicit market, as always, remains open for business.

📈 Dog Walkers

$PLNH ( ▼ 7.93% ) Gets Green Light In Florida

Planet 13 just unlocked a product category it's been missing in one of the largest cannabis markets in the country.

The vertically integrated multi-state operator announced that its Florida operations have received OMMU approval for a purpose-built BHO extraction facility, completing the final major infrastructure investment in the company's Florida buildout and enabling Planet 13 to compete in the state's full concentrate category for the first time.

The approximately 3,465-square-foot laboratory supports production of six BHO concentrate formats — Badder, Shatter, Crumble, Sugar, Sauce, and Diamonds — along with Live Resin Disposable and C-Cell vaporizer cartridges. Products will roll out across Planet 13's Florida dispensary locations in the coming months as individual SKUs receive approval.

The timing matters. According to Headset market data, Florida's concentrate segment generated approximately $125 million in retail sales — a meaningful revenue pool that Planet 13 has been largely unable to tap until now. In a state with over 600 dispensaries and intensifying competition, offering a complete product selection isn't a luxury — it's a competitive necessity.

Co-Chairman and Co-CEO Robert Groesbeck framed the approval as the culmination of a deliberate repositioning effort: "We've invested meaningfully in cultivation quality, post-harvest processing, and now extraction infrastructure. With this facility operational, we're positioned to serve the full Florida concentrate category for the first time."

The structural impact goes beyond just adding SKUs. Concentrates typically carry higher margins than flower, and the ability to produce in-house rather than relying on third-party processing preserves those margins within Planet 13's vertically integrated model.

For a company that has been investing heavily in Florida while the broader market debates the state's future, the extraction approval represents the kind of operational milestone that translates directly into revenue capture and margin expansion.

🗞️ The News

📺 Trade To Black

Cannabis Uplisting Rumours Keep Growing | TTB Presented by Flowhub

• Uplisting Speculation: Growing conversation around whether cannabis stocks could finally move onto the NYSE and Nasdaq, and what that would mean for MSOs and institutional capital flows.

• Market Sentiment: Scott Grossman of Vindico Capital breaks down why the market feels different right now, what investors may be overlooking, and whether the industry is quietly building momentum.

• Digital Payments Push: Flowhub launches a Pay by Bank integration powered by Aeropay, accelerating the shift from cash to compliant digital payments as dispensaries report larger average order values from ACH and app-based transactions.

• Big Picture: Cash transactions are declining, digital adoption is rising, and investors are paying closer attention — signaling that cannabis retail infrastructure and stock market access may both be approaching inflection points.